Cargando…
Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
OBJECTIVE: The aim of this study is to assess the prevalence of gastroprotection and identify the main factors that influence the taking of protective drugs by the adult population treated with non-steroidal anti-inflammatory drugs (NSAID). METHODS: This study was cross-sectional, conducted by inclu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418831/ https://www.ncbi.nlm.nih.gov/pubmed/32832889 http://dx.doi.org/10.15386/mpr-1533 |
_version_ | 1783569765603737600 |
---|---|
author | Shabani, Driton Murtezani, Ardiana Tahirbegolli, Bernard Juniku-Shkololli, Argjira Ibraimi, Zana |
author_facet | Shabani, Driton Murtezani, Ardiana Tahirbegolli, Bernard Juniku-Shkololli, Argjira Ibraimi, Zana |
author_sort | Shabani, Driton |
collection | PubMed |
description | OBJECTIVE: The aim of this study is to assess the prevalence of gastroprotection and identify the main factors that influence the taking of protective drugs by the adult population treated with non-steroidal anti-inflammatory drugs (NSAID). METHODS: This study was cross-sectional, conducted by including a contingent of 800 users of primary health care services (n=369, 46% males and n=431, 54% females). Included in the study were individuals of both genders aged 18+ who sought counselling or treatment during the three-month period. The data collection of this study was based on the completion of a structured questionnaire, which included questions related to the use of NSAIDs, the way these drugs were prescribed and administered and the simultaneous taking of gastroprotective drugs. RESULTS: The prevalence of the gastroprotective drugs use was higher among the elderly, individuals living in urban areas, those with higher education, those with daily use of NSAID, individuals receiving prescriptions from their own doctors, and those suffering from side effects from the use of NSAID, as well as subjects that had a longer duration of NSAID use. Diclofenac was the most prescribed NSAID. Gastric pain and dizziness were the most experienced side effects. CONCLUSION: This paper demonstrates the need to improve the quality of primary health care service through informing and educating patients regarding the need to take gastro-protective drugs for those at high risk of adverse effects manifested by the use of NSAIDs. |
format | Online Article Text |
id | pubmed-7418831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Iuliu Hatieganu University of Medicine and Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-74188312020-08-20 Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users Shabani, Driton Murtezani, Ardiana Tahirbegolli, Bernard Juniku-Shkololli, Argjira Ibraimi, Zana Med Pharm Rep Original Research OBJECTIVE: The aim of this study is to assess the prevalence of gastroprotection and identify the main factors that influence the taking of protective drugs by the adult population treated with non-steroidal anti-inflammatory drugs (NSAID). METHODS: This study was cross-sectional, conducted by including a contingent of 800 users of primary health care services (n=369, 46% males and n=431, 54% females). Included in the study were individuals of both genders aged 18+ who sought counselling or treatment during the three-month period. The data collection of this study was based on the completion of a structured questionnaire, which included questions related to the use of NSAIDs, the way these drugs were prescribed and administered and the simultaneous taking of gastroprotective drugs. RESULTS: The prevalence of the gastroprotective drugs use was higher among the elderly, individuals living in urban areas, those with higher education, those with daily use of NSAID, individuals receiving prescriptions from their own doctors, and those suffering from side effects from the use of NSAID, as well as subjects that had a longer duration of NSAID use. Diclofenac was the most prescribed NSAID. Gastric pain and dizziness were the most experienced side effects. CONCLUSION: This paper demonstrates the need to improve the quality of primary health care service through informing and educating patients regarding the need to take gastro-protective drugs for those at high risk of adverse effects manifested by the use of NSAIDs. Iuliu Hatieganu University of Medicine and Pharmacy 2020-07 2020-07-22 /pmc/articles/PMC7418831/ /pubmed/32832889 http://dx.doi.org/10.15386/mpr-1533 Text en This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Original Research Shabani, Driton Murtezani, Ardiana Tahirbegolli, Bernard Juniku-Shkololli, Argjira Ibraimi, Zana Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users |
title | Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users |
title_full | Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users |
title_fullStr | Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users |
title_full_unstemmed | Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users |
title_short | Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users |
title_sort | non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418831/ https://www.ncbi.nlm.nih.gov/pubmed/32832889 http://dx.doi.org/10.15386/mpr-1533 |
work_keys_str_mv | AT shabanidriton nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers AT murtezaniardiana nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers AT tahirbegollibernard nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers AT junikushkololliargjira nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers AT ibraimizana nonsteroidalantiinflammatorydrugsandgastroprotectioninprimaryhealthcareusers |